Results 111 to 120 of about 5,264,822 (290)

Production, crystallization, and preliminary X−ray analysis of rabbit skeletal muscle troponin complex consisting of troponin C and fragment (1−47) of troponin I

open access: yes, 1997
Troponin is a ternary protein complex consisting of subunits TnC, TnI, and TnT, and plays a key role in calcium regulation of the skeletal and cardiac muscle contraction.
Kobayashi, T.   +17 more
core   +1 more source

Long‐term cardiovascular outcomes of immune checkpoint inhibitor‐related myocarditis: A large single‐centre analysis

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1237-1245, April 2025.
Abstract Aims Immune checkpoint inhibitors (ICI) are the cornerstone of modern oncology; however, side effects such as ICI‐related myocarditis (irM) can be fatal. Recently, Bonaca proposed criteria for irM; however, it is unknown if they correlate well with cardiovascular (CV) ICI‐related adverse events.
Lorenzo Braghieri   +12 more
wiley   +1 more source

The Role of Cardiac Troponin and Other Emerging Biomarkers Among Athletes and Beyond: Underlying Mechanisms, Differential Diagnosis, and Guide for Interpretation

open access: yesBiomolecules
Cardiovascular (CV) disease remains the leading cause of morbidity and mortality worldwide, highlighting the necessity of understanding its underlying molecular and pathophysiological pathways.
Mihail Celeski   +11 more
doaj   +1 more source

Evaluation of cardiac markers and some serumic biochemical parameters in seropositive horses with equine influenza [PDF]

open access: yesĀsīb/shināsī-i Darmāngāhī-i Dāmpizishkī, 2013
This study was performed to evaluate the effect of influenza in horses on the electrocardiogram changes, cardiac arrhythmias and concentration of cardiac troponin in serum and serumic activity of some enzymes.
ali hassanpour   +2 more
doaj  

The effect of proteolytic enzymes on the troponin complex [PDF]

open access: yesFEBS Letters, 1971
Drabikowski, W.   +4 more
openaire   +2 more sources

Troponin-I release after cardiac surgery with different surgical techniques and post-operative neurological outcomes-0

open access: yes, 2011
Copyright information:Taken from "Troponin-I release after cardiac surgery with different surgical techniques and post-operative neurological outcomes"McGill Journal of Medicine : MJM 2006;9(2):88-94.Published online Jan 2006PMCID:PMC2323524.Copyright ©
Akhshay Kumar Bisoi (90849)   +3 more
core   +1 more source

Myocardial inflammation is associated with impaired mitochondrial oxidative capacity in ischaemic cardiomyopathy

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1246-1255, April 2025.
Abstract Aims Myocardial inflammation and impaired mitochondrial oxidative capacity are hallmarks of heart failure (HF) pathophysiology. The extent of myocardial inflammation in patients suffering from ischaemic cardiomyopathy (ICM) or dilated cardiomyopathy (DCM) and its association with mitochondrial energy metabolism are unknown.
Julius Borger   +15 more
wiley   +1 more source

Assessment of Troponin Levels as a Biomarker of Myocardial Injury in Patients with Fatal Covid-19 for the Period 2020 to 2022: A Literature Review

open access: yesKufa Journal for Nursing Sciences
Background: COVID-19 initially described at the end of 2019. COVID-19 is caused by an uncommon ‎coronavirus infection. Since then, it has been spreading rapidly and has caused a global pandemic, infecting more than 29 million people and causing more ...
Zainab Tawfeeq Al-Joubouri   +3 more
doaj   +1 more source

Structures reveal details of small molecule binding to cardiac troponin

open access: yes, 2016
In cardiac and skeletal muscle, the troponin complex turns muscle contraction on and off in a calcium-dependent manner. Many small molecules are known to bind to the troponin complex to modulate its calcium binding affinity, and this may be useful in a ...
West, Frederick   +7 more
core   +1 more source

Considerations for drug trials in hypertrophic cardiomyopathy

open access: yesESC Heart Failure, Volume 12, Issue 2, Page 1095-1112, April 2025.
Abstract Hypertrophic cardiomyopathy (HCM) is a heterogeneous condition with potentially serious manifestations. Management has traditionally comprised therapies to palliate symptoms and implantable cardioverter‐defibrillators to prevent sudden cardiac death. The need for disease‐modifying therapies has been recognized for decades.
John P. Farrant   +17 more
wiley   +1 more source

Home - About - Disclaimer - Privacy